The rise of personalized medicine, which tailors treatment to an individual’s genetic makeup, has brought significant scientific progress but also serious ethical concerns. In my view, although this approach has the potential to greatly improve healthcare outcomes, it must be carefully regulated, and access should be expanded in a fair and responsible manner.
One of the main ethical issues surrounding personalized medicine is the protection of genetic data. Genetic information is extremely sensitive, and if it is leaked or misused, individuals may face discrimination from employers or insurance companies. Moreover, many patients may not fully understand how their data is stored or shared, raising concerns about informed consent. Without strict legal frameworks, scientific advancement could come at the cost of personal privacy and trust in healthcare systems.
Despite these concerns, I believe access to personalized medicine should be made as universal as possible. Limiting such treatments to wealthy individuals would deepen existing healthcare inequalities and create a two-tier medical system. When properly regulated, personalized medicine can help doctors provide more effective treatments, reduce unnecessary side effects, and improve long-term health outcomes for a wide range of patients. From this perspective, ethical safeguards should be used to support wider access rather than restrict innovation.
In conclusion, personalized medicine represents a major step forward in healthcare, but it raises important ethical questions related to privacy and discrimination. While scientific progress should not be halted, it must be balanced with strong ethical standards to ensure fairness, data protection, and equal access for all members of society.